Health IT

Cara Medical's AI-powered CARA System gets FDA approval, promising to revolutionize complex heart procedures with 3D visualization of the conduction system.

A new partnership between Amilia and CampDoc promises to eliminate data headaches for directors and enhance child safety through integrated, secure technology.

Fresh off record profits, World Gym details its strategy for global growth, betting on AI health platforms and high-margin services to reshape the industry.

By fitting into existing hospital rooms, Mevion's newly CE-Marked proton therapy system aims to slash costs and expand access to advanced cancer treatment.

Japan becomes the first nation outside Israel to approve Alpha DaRT, a highly precise therapy for untreatable head and neck cancers. Here’s what it means.

Verdiva Bio's VRB-101 aims to be the first once-weekly oral GLP-1, a potential game-changer for patients tired of daily pills and injections.

With new backing from One Six 8 Ventures, health tech firm Respiree accelerates its US and Canadian expansion of its FDA-cleared AI platform.

A new modular filter cartridge promises to cut air purifier ownership costs by 60%, tackling a major barrier to clean indoor air for many households.

A new IDC MarketScape report names LexisNexis a leader, highlighting its unique dynamic data technology that's reshaping how payers manage complex networks.

With $14.2M in new funding, Handl Health is using AI and data to dismantle one-size-fits-all insurance, promising lower costs and better care.

Blue Cross and Blue Shield of Kansas is the first health plan to earn URAC's new Health Equity Accreditation, setting a national precedent for accountability.

A new AI platform, Alti, claims to boost productivity and retention by creating a 'digital twin' to optimize employee well-being. But can it deliver?

Dr. Mark Leenay joins Cohere Health's board, a strategic move to blend deep clinical and health plan expertise with the firm's advanced AI platform.

For the 11th straight year, OTAVA lands on CRN's prestigious MSP 500 list. We explore how its focus on security, compliance, and a human-first approach sets it apart.

With double-digit growth, a new AI-focused CTO, and major investor backing, XiFin is poised to redefine healthcare's complex financial future.

Fresh off strong 2025 earnings, AtriCure will detail its growth strategy and innovative cardiac portfolio at a major life sciences conference.

NorthX Biologics and Demeetra have partnered to offer a streamlined, royalty-free path from gene to GMP, tackling key bottlenecks for biotech startups.

With a promise of cellular renewal via exosomes, (plated) Skin Science is leading a biotech revolution. But can it navigate the hype and regulatory hurdles?

Amidst industry-wide regulatory challenges, Meridian secures critical IVDR certification for its Alethia assays, ensuring continued market access in Europe.

A pivotal trial for a rare muscle disease failed its main goal, but promising data in a specific patient group offers a new, complex path forward.